Form 8-K Evoke Pharma Inc For: Aug 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Evoke Pharma (EVOK) Tops Q2 EPS by 8c
August 13, 2015 4:37 PM EDTEvoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.52), $0.08 better than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
... More